Mats Bojestig
- Nephrology top 2%
- Chronic Kidney Disease and Diabetes 5
-
- Diabetes Management and Research 6
- Neurological and metabolic disorders 2
-
- Acute Myocardial Infarction Research 5
- Genetics top 10%
- Diabetes and associated disorders 6
- Ophthalmology top 5%
- Retinal Diseases and Treatments 3
-
- Health Systems, Economic Evaluations, Quality of Life 4
-
- Clinical practice guidelines implementation 3
- Co-authors
- Johnny LudvigssonHans J. ArnqvistBengt E. KarlbergGöran HermanssonMaria NordwallBertil LindahlGunilla LindströmFredrik H. Nyström
- Partner nations
- SwedenUnited KingdomSpain
In The Last Decade
Mats Bojestig
17 papers receiving 904 citations
Peers
Comparison fields: 5 of 91
- Nephrology 245
- Endocrinology, Diabetes and Metabolism 512
- Cardiology and Cardiovascular Medicine 218
- Genetics 252
- Ophthalmology 81
Countries citing papers authored by Mats Bojestig
This map shows the geographic impact of Mats Bojestig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mats Bojestig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mats Bojestig more than expected).
Fields of papers citing papers by Mats Bojestig
This network shows the impact of papers produced by Mats Bojestig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mats Bojestig. The network helps show where Mats Bojestig may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mats Bojestig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 18 | |
| 2 | 2014 | 47 | |
| 3 | 2012 | 11 | |
| 4 | 2011 | 24 | |
| 5 | 2010 | 11 | |
| 6 | 2009 | 83 | |
| 7 | 2009 | 33 | |
| 8 | 2007 | 29 | |
| 9 | 2007 | 23 | |
| 10 | 2006 | 57 | |
| 11 | 2004 | 145 | |
| 12 | Declining incidence of severe retinopathy in a population of Type 1 diabetes | 2001 | 1 |
| 13 | 2001 | 28 | |
| 14 | Persistent decrease in nephropathy in Type 1 diabetes | 2000 | 1 |
| 15 | 2000 | 19 | |
| 16 | 1998 | 17 | |
| 17 | 1997 | 52 | |
| 18 | 1996 | 53 | |
| 19 | 1994 | 327 |
About Mats Bojestig
Mats Bojestig is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Ophthalmology, having authored 19 papers that have together received 979 indexed citations. Recurring topics across this work include Diabetes and associated disorders (6 papers), Diabetes Management and Research (6 papers), Acute Myocardial Infarction Research (5 papers), Chronic Kidney Disease and Diabetes (5 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Clinical practice guidelines implementation (3 papers), Retinal Diseases and Treatments (3 papers) and Neurological and metabolic disorders (2 papers). The work is most often cited by research in Nephrology (245 citations), Endocrinology, Diabetes and Metabolism (512 citations) and Cardiology and Cardiovascular Medicine (218 citations). Mats Bojestig has collaborated with scholars based in Sweden, United Kingdom and Spain. Frequent co-authors include Johnny Ludvigsson, Hans J. Arnqvist, Bengt E. Karlberg, Göran Hermansson, Maria Nordwall, Bertil Lindahl, Gunilla Lindström, Fredrik H. Nyström, Boel Andersson Gäre and Thomas Bodenheimer. Their work appears in journals such as New England Journal of Medicine, PLoS ONE and Diabetes Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.